Inmune Bio (INMB) Return on Equity [ROE] (2018 - 2026)
Inmune Bio (INMB) reported Return on Equity [ROE] of -101.01% for Q2 2026, up 91.09 percentage points from -192.10% a year earlier and up 99.65 percentage points from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Inmune Bio posted Return on Equity [ROE] of -170.38%, down 47.58 percentage points from FY2024.
- Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -131.16 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -122.80% in FY2024 (-61.76 pp), -61.04% in FY2023 (-24.06 pp), -36.99% in FY2022 (+12.02 pp) and -49.01% in FY2021 (-9.79 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q4 2023.
- Year over year, Return on Equity [ROE] gained in 1 of the last eight quarters, with an average year-over-year change of -41.59 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 91.09 percentage points); the low point was Q3 2025 (a drop of 78.57 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -200.66% (Q1 2026), -193.79% (Q4 2025) and -189.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Inmune Bio | 53.37 Mn | -38.88 Mn | - | -101.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -101.01% |
| Mar 31, 2026 | -200.66% |
| Dec 31, 2025 | -193.79% |
| Sep 30, 2025 | -189.42% |
| Jun 30, 2025 | -192.10% |
| Mar 31, 2025 | -134.44% |
| Dec 31, 2024 | -120.49% |
| Sep 30, 2024 | -110.86% |
| Jun 30, 2024 | -117.17% |
| Mar 31, 2024 | -104.74% |
| Dec 31, 2023 | -73.19% |
| Sep 30, 2023 | -57.10% |
| Jun 30, 2023 | -48.93% |
| Mar 31, 2023 | -44.88% |
| Dec 31, 2022 | -42.61% |
| Sep 30, 2022 | -44.54% |
| Jun 30, 2022 | -43.06% |
| Mar 31, 2022 | -40.43% |
| Dec 31, 2021 | -34.62% |
| Sep 30, 2021 | -35.50% |
API Access
Inmune Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();